Cboe joins lawsuit against CFTC single-stock perpetuals approval
Alpha Vantage · Simply Wall St · · AI-summarised by FinFlash
Cboe Global Markets has joined a legal challenge against the CFTC's approval of single-stock perpetual derivatives in U.S. markets, citing investor protection and oversight concerns. The exchange aligns with other market participants questioning whether these products fit existing regulatory frameworks. Cboe is defending its established, regulation-friendly derivatives lineup rather than pursuing every product regulators permit.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.